News Details

FDA Issues Regulatory Update

The United States Food and Drug Administration (FDA) has issued its regulatory update for stakeholders.  The FDA update focuses on nitrosamines in medications, the latest FDA guidance documents open for public comment, and the latest FDA public meetings and workshops (among other topics).  To read the FDA regulatory update for stakeholders, use the link below.